Population-based Breast Cancer Prognosis by Transcriptionial Profiling

The invention is a biomarker marker test for breast cancer prognosis the identification of specific patients with the high risk of recurrence. The biomarkers have been designed based on population studies and the result is a 28-gene signature that is a highly accurate predictor of disease-free survival and overall survival. The studies also idenftified a 14-gene predictor of nodal status and a 9-gene predictor of tumor grade.

Intellectual Property Status
Disclosure 387. Patent Pending

Inventors
Jame Abraham, Lan Guo